粪便碳水化合物降解菌与降低下消化道GVHD发生率相关
该回顾性队列对90例异基因造血干细胞移植患者粪便进行宏基因组测序,发现植入前后特定副拟杆菌和拟杆菌减少与下消化道GVHD风险相关,且木糖苷酶等碳水化合物活性酶基因丰度与风险降低显著相关。
要点
- 植入前后副拟杆菌和拟杆菌特定菌种减少与下消化道GVHD风险相关。
- 木糖苷酶基因丰度与下消化道GVHD风险降低显著相关。
- 未发生GVHD者中副拟杆菌和拟杆菌丰度与CAZymes显著相关。
核心结论
- 特定碳水化合物降解菌及其CAZymes功能与下消化道GVHD风险降低相关。
研究设计与样本
- 回顾性队列,对90例异基因造血干细胞移植患者粪便进行宏基因组测序。
主要发现
- 植入前后特定副拟杆菌和拟杆菌物种减少与下消化道GVHD风险相关。
- 未发生下消化道GVHD者中P. merdae、P. distasonis和B. ovatus丰度与CAZymes显著相关。
- 木糖苷酶特定基因丰度与下消化道GVHD风险降低显著相关。
临床怎么用
- 上述菌群及CAZymes基因丰度或可作为下消化道GVHD风险分层参考。
局限性
- 回顾性队列设计,样本量有限(N=90),关联性不能推断因果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Lower gastrointestinal graft-versus-host disease (LGI-GVHD) carries morbidity and mortality for patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT), with critical contributions from the intestinal microbiome. In a retrospective cohort of metagenomic sequencing of stool from patients with allo-HSCT (N = 90), we found that a reduction in specific Parabacteroides and Bacteroides species around the time of engraftment contributes to LGI-GVHD risk. Given the known diverse carbohydrate-degrading functionality of these bacteria, we investigated gene abundances for carbohydrate-active enzymes (CAZymes) and found that Parabacteroides merdae, P distasonis, and Bacteroides ovatus abundances were significantly correlated with CAZymes in patients who did not develop LGI-GVHD compared with those who did. The specific gene abundances of xylosidase, which contribute to the degradation of xylose-containing polysaccharides, were significantly associated with a reduced risk of LGI-GVHD. All these findings show the importance of the carbohydrate-degrading functionality of putative beneficial bacteria in mediating risk of LGI-GVHD.
引用
- Fan C, Hayase T, Chang CC, et al. Fecal carbohydrate-degrading bacteria are associated with reduced incidence of lower gastrointestinal GVHD. Blood Adv. 2026. PMID: 41558030. doi:10.1182/bloodadvances.2025016780
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。